|
ADPT
|
Adaptive Biotechnologies Corporation
|
US
|
NASDAQ
|
|
ATOS
|
Atossa Genetics Inc.
|
US
|
NASDAQ
|
|
BIAF
|
bioAffinity Technologies, Inc.
|
US
|
NASDAQ
|
|
CEMI
|
Chembio Diagnostics, Inc.
|
US
|
NASDAQ
|
|
CODX
|
Co-Diagnostics, Inc.
|
US
|
NASDAQ
|
|
CVET
|
Covetrus, Inc.
|
US
|
NASDAQ
|
|
DMTK
|
DermTech, Inc.
|
US
|
NASDAQ
|
|
HLTH
|
Cue Health Inc.
|
US
|
NASDAQ
|
|
HSIC
|
Henry Schein, Inc.
|
US
|
NASDAQ
|
|
IDXG
|
Interpace Diagnostics Group, Inc.
|
US
|
NASDAQ
|
|
INBS
|
Intelligent Bio Solutions Inc.
|
US
|
NASDAQ
|
|
LH
|
Laboratory Corporation of America Holdings
|
US
|
NYSE
|
|
MYGN
|
Myriad Genetics, Inc.
|
US
|
NASDAQ
|
|
MYNZ
|
Mainz Biomed B.V.
|
US
|
NASDAQ
|
|
NSTG
|
NanoString Technologies, Inc.
|
US
|
NASDAQ
|
|
OCX
|
OncoCyte Corporation
|
US
|
NASDAQ
|
|
OPK
|
OPKO Health Inc.
|
US
|
NASDAQ
|
|
TRIB
|
Trinity Biotech plc
|
US
|
NASDAQ
|
|
TTOO
|
T2 Biosystems, Inc.
|
US
|
NASDAQ
|
|
LDX
|
Lumos Diagnostics Holdings Limited
|
AU
|
ASX
|